Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-Δ12,14-prostaglandin J2 requires Nrf2

Cellular Immunology

Volumn 262, Issue 1, 2010, Pages 18-27

  Bancos, Simona ^a   Baglole, Carolyn J ^a   Rahman, Irfan ^a   Phipps, Richard P ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

15d PGJ2; B cell malignancy; B lymphocytes; Heme oxygenase 1; Nrf2

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; HEME OXYGENASE 1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL LINEAGE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; MANTLE CELL LYMPHOMA; MOUSE; MULTIPLE MYELOMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; HUMANS; LEUKEMIA, B-CELL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; PROSTAGLANDIN D2; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

MUS;

EID: 77349087094     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.12.003     Document Type: Article

References (53)

1. Ryter S.W., and Choi A.M. Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy. Am. J. Respir. Cell Mol. Biol. 41 (2009) 251-260
2. Sass G., Leukel P., Schmitz V., Raskopf E., Ocker M., Neureiter D., Meissnitzer M., Tasika E., Tannapfel A., and Tiegs G. Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Int. J. Cancer 123 (2008) 1269-1277
3. Goodman A.I., Choudhury M., da Silva J.L., Schwartzman M.L., and Abraham N.G. Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc. Soc. Exp. Biol. Med. 214 (1997) 54-61
4. Maines M.D., and Abrahamsson P.A. Expression of heme oxygenase-1 (HSP32) in human prostate: normal hyperplastic, and tumor tissue distribution. Urology 47 (1996) 727-733
5. Rushworth S.A., and MacEwan D.J. HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood 111 (2008) 3793-3801
6. Choi B.M., Pae H.O., Jeong Y.R., Kim Y.M., and Chung H.T. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun. 327 (2005) 1066-1071
7. Du D., Chang S., Chen B., Zhou H., and Chen Z.K. Heme oxygenase-1 protects INF-gamma primed endothelial cells from Jurkat T-cell adhesion. Transplant Proc. 39 (2007) 3449-3451
8. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T.M., Atkinson M.A., and Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 165 (2004) 1045-1053
9. Armitage J.O., and Weisenburger D.D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. J. Clin. Oncol. 16 (1998) 2780-2795
10. Molina A. A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma. Annu. Rev. Med. 59 (2008) 237-250
11. Jazirehi A.R., and Bonavida B. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention. Oncogene 24 (2005) 2121-2143
12. Kurtin P.J. Mantle cell lymphoma. Adv. Anat. Pathol. 5 (1998) 376-398
13. Kyle R.A., and Rajkumar S.V. Multiple myeloma. N. Engl. J. Med. 351 (2004) 1860-1873
14. Smith M.R. Mantle cell lymphoma: advances in biology and therapy. Curr. Opin. Hematol. 15 (2008) 415-421
15. Sonneveld P. Multidrug resistance in haematological malignancies. J. Intern. Med. 247 (2000) 521-534
16. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23 (2002) 144-150
17. Ray D.M., Akbiyik F., and Phipps R.P. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms. J. Immunol. 177 (2006) 5068-5076
18. Keyse S.M., and Tyrrell R.M. Induction of the heme oxygenase gene in human skin fibroblasts by hydrogen peroxide and UVA (365 nm) radiation: evidence for the involvement of the hydroxyl radical. Carcinogenesis 11 (1990) 787-791
19. Baglole C.J., Sime P.J., and Phipps R.P. Cigarette smoke-induced expression of heme oxygenase-1 in human lung fibroblasts is regulated by intracellular glutathione. Am. J. Physiol. Lung Cell Mol. Physiol. 295 (2008) 624-636
20. Hong H.Y., Jeon W.K., and Kim B.C. Up-regulation of heme oxygenase-1 expression through the Rac1/NADPH oxidase/ROS/p38 signaling cascade mediates the anti-inflammatory effect of 15-deoxy-delta 12,14-prostaglandin J2 in murine macrophages. FEBS Lett. 582 (2008) 861-868
21. Alvarez-Maqueda M., El Bekay R., Alba G., Monteseirín J., Chacón P., Vega A., Martín-Nieto J., Bedoya F.J., Pintado E., and Sobrino F. 15-Deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. J. Biol. Chem. 279 (2004) 21929-21937
22. Lim H.J., Lee K.S., Lee S., Park J.H., Choi H.E., Ho S.H., Kwak H.J., and Park H.Y. 15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf2 pathway in rat vascular smooth muscle cells. Toxicol. Appl. Pharmacol. 223 (2007) 20-27
23. Kim J.W., Li M.H., Jang J.H., Na H.K., Song N.Y., Lee C., Johnsos J.A., and Surh Y.J. 15-Deoxy-Delta (12,14)-prostaglandin J(2) rescues PC12 cells from H(2)O(2)-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. Biochem. Pharmacol. 76 (2008) 1577-1589
24. Lee J.M., and Johnson J.A. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J. Biochem. Mol. Biol. 37 (2004) 139-143
25. Venugopal R., and Jaiswal A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. USA 93 (1996) 14960-14965
26. Padilla J., Leung E., and Phipps R.P. Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. Clin. Immunol. 103 (2002) 22-33
27. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., and Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 (1997) 313-322
28. Goh B.J., Tan B.T., Hon W.M., Lee K.H., and Khoo H.E. Nitric oxide synthase and heme oxygenase expressions in human liver cirrhosis. World J. Gastroenterol. 12 (2006) 588-594
29. Slebos D.J., Ryter S.W., van der Toorn M., Liu F., Guo F., Baty C.J., Karlsson J.M., Watkins S.C., Kim H.P., Wang X., Lee J.S., Postma D.S., Kauffman H.F., and Choi A.M.K. Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am. J. Respir. Cell Mol. Biol. 36 (2007) 409-417
30. Kim H.P., Wang X., Galbiati F., Ryter S.W., and Choi A.M. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J. 18 (2008) 1080-1089
31. Lin Q., Weis S., Yang G., Weng Y.H., Helston R., Rish K., Smith A., Bordner J., Polte T., Gaunitz F., and Dennery P.A. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J. Biol. Chem. 282 (2007) 20621-20633
32. Andreadi C.K., Howells L.M., Atherfold P.A., and Manson M.M. Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol. Pharmacol. 69 (2006) 1033-1040
33. Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., and Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 116 (2006) 984-995
34. Gilroy D.W., and Colville-Nash P.R. New insights into the role of COX 2 in inflammation. J. Mol. Med. 78 (2000) 121-129
35. Ryan E.P., Pollock S.J., Murant T.I., Bernstein S.H., Felgar R.E., and Phipps R.P. Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J. Immunol. 174 (2005) 2619-2626
36. Jozkowicz A., Was H., Taha H., Kotlinowski J., Mleczko K., Cisowski J., Weigel G., and Dulak J. 15d-PGJ2 Upregulates Synthesis of IL-8 in endothelial cells through induction of oxidative stress. Antioxid. Redox Signal 10 (2008) 2035-2046
37. Poss K.D., and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. USA 94 (1997) 10925-10930
38. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103 (1999) 129-135
39. Benallaoua M., Francois M., Batteux F., Thelier N., Shyy J.Y., Fitting C., Tsagris J., Boczkowski J., Savouret J.F., Corvol M.T., Poiraudeau S., and Rannou F. Pharmacologic induction of heme oxygenase 1 reduces acute inflammatory arthritis in mice. Arthritis Rheum. 56 (2007) 2585-2594
40. Mayerhofer M., Gleixner K.V., Mayerhofer J., Hoermann G., Jaeger E., Aichberger K.J., Ott R.G., Greish K., Nakamura H., Derdak S., Samorapoompichit P., Pickl W.F., Sexl V., Esterbauer H., Schwarzinger I., Sillaber C., Maeda H., and Valent P. Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Blood 111 (2008) 2200-2210
41. Mayerhofer M., Florian S., Krauth M.T., Aichberger K.J., Bilban M., Marculescu R., Printz D., Fritsch G., Wagner O., Selzer E., Sperr W.R., Valent P., and Sillaber C. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res. 64 (2004) 3148-3154
42. Jozkowicz A., Was H., and Dulak J. Heme oxygenase-1 in tumors: is it a false friend?. Antioxid. Redox Signal 9 (2007) 2099-2117
43. Kaneda H., Ohno M., Taguchi J., Togo M., Hashimoto H., Ogasawara K., Aizawa T., Ishizaka N., and Nagai R. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler. Thromb Vasc. Biol. 22 (2002) 1680-1685
44. Kimpara T., Takeda A., Watanabe K., Itoyama Y., Ikawa S., Watanabe M., Arai H., Sasaki H., Higuchi S., Okita N., Takase S., Saito H., Takahashi K., and Shibahara S. Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum. Genet. 100 (1997) 144-147
45. Yamada N., Yamaya M., Okinaga S., Nakayama K., Sekizawa K., Shibahara S., and Sasaki H. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 66 (2000) 187-195
46. Lo S.S., Lin S.C., Wu C.W., Chen J.H., Yeh W.I., Chung M.Y., and Lui W.Y. Heme oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion. Ann. Surg. Oncol. 14 (2007) 2250-2256
47. Alam J., and Cook J.L. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr. Pharm. Des. 9 (2003) 2499-2511
48. Vargas M.R., Pehar M., Cassina P., Palma L.M., Thompson J.A., Beckman J.S., and Barbeito L. Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival. J. Biol. Chem. 280 (2005) 25571-25579
49. Thimmulappa R.K., Scollick C., Traore K., Yates M., Trush M.A., Liby K.T., Sporn M.B., Yamamoto M., Kensler T.W., and Biswal S. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Biochem. Biophys. Res. Commun. 351 (2006) 883-889
50. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., Yamamoto M., Petrache I., Tuder R.M., and Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114 (2004) 1248-1259
51. Rangasamy T., Guo J., Mitzner W.A., Roman J., Singh A., Fryer A.D., Yamamoto M., Kensler T.W., Tuder R.M., Georas S.N., and Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J. Exp. Med. 202 (2005) 47-59
52. Li J., Stein T.D., and Johnson J.A. Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice. Physiol. Genomics 18 (2004) 261-272
53. Ryter S.W., Alam J., and Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86 (2006) 583-650